| Financial Year |
March 31 2023 |
| Monetary Funds |
456,724,688.34 |
| Held-for-trading Financial Assets |
153,126,568.08 |
| Notes Receivable |
395,989.58 |
| Accounts Receivable |
678,776,186.86 |
| Advances to Suppliers |
29,735,900.68 |
| Other Receivables |
59,052,987.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
333,843,830.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,027,570.95 |
| Total Current Assets |
1,825,377,004.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
26,177,591.88 |
| Long-term Equity Investment |
276,204,970.94 |
| Investment Properties |
373,184,780.25 |
| Fixed Assetes |
499,170,872.75 |
| Under-construction Projects |
557,410.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
148,477,490.97 |
| R&D expenses |
7,317,991.94 |
| Goodwill |
124,236,999.67 |
| Long-Term Deferred and Prepaid Expenses |
8,083,808.76 |
| Deferred Income Tax Assets |
73,583,411.82 |
| Other Non-Current Assets |
6,956,000.00 |
| Sub-Total of Non-Current Assets |
1,688,784,870.99 |
| Total Assets |
3,514,161,875.38 |
| Short-Term Loans |
354,313,320.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,613,102.71 |
| Accounts Payable |
338,293,565.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,095,539.30 |
| Taxes Payable |
45,470,981.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
48,269,410.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
261,816,283.87 |
| Other Current Liabilities |
5,050,465.43 |
| Sub-Total of Current Liabilities |
1,199,634,833.04 |
| Long-term Loans |
382,696,058.39 |
| Bonds Payable |
677,469,807.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
471,833.33 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
514,012.58 |
| Sub-Total of Non-Current Liabilities |
1,064,951,508.81 |
| Total Liabilities |
2,264,586,341.85 |
| Paid-In Capital(Or Share Stock) |
863,767,466.00 |
| Capital Surplus |
1,358,407,528.46 |
| Surplus Reserve |
72,600,033.72 |
| LESS:Treasury Stock |
257,559,209.50 |
| Undistributed Profits |
-1,023,917,053.85 |
| Minority Stockholder's Interest |
20,202,335.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,229,373,197.81 |
| Owner's Equity（Stockholder's Equity） |
1,249,575,533.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,514,161,875.38 |
